Verastem, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Verastem, Inc. (VSTM) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.18% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-20
- Verastem, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.18%.
- Verastem, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.14%.
- Verastem, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.04%.
- Verastem, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.71%, a 127.31% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2024-12-31 | -0.18% 10-K · filed 2025-03-20 |
| 2023-12-31 | -0.14% 10-K · filed 2025-03-20 |
| 2022-12-31 | -0.04% 10-K · filed 2024-03-14 |
| 2021-12-31 | -0.71% 10-K · filed 2023-03-14 |
| 2020-12-31 | 2.60% 10-K · filed 2022-03-28 |
| 2019-12-31 | -0.43% 10-K · filed 2021-03-18 |
| 2018-12-31 | -0.52% 10-K · filed 2020-03-11 |
| 2017-12-31 | 0.20% 10-K · filed 2019-03-12 |
| 2016-12-31 | -1.26% 10-K · filed 2018-03-13 |
| 2015-12-31 | 3.52% 10-K · filed 2017-03-23 |
| 2014-12-31 | 0.35% 10-K · filed 2016-03-03 |
| 2013-12-31 | -0.40% 10-K · filed 2015-03-10 |
| 2012-12-31 | -0.46% 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |